Press releases

17
Feb 2014
21:30 E.S.T.

Cellectis and Servier announce collaboration in allogeneic cell therapy: UCART19 to treat leukemia and 5 product candidates targeting solid tumors

Read more
5
Feb 2014
21:30 E.S.T.

US Patent Institutions recognize the patentability of Institut Pasteur/Cellectis early inventions on Meganucleases

Read more
4
Feb 2014
21:30 E.S.T.

Cellectis grants genOway an exclusive sublicense for its homologous recombination technology in the field of genetically modified rodent models

Read more
30
Jan 2014
21:30 E.S.T.

Cellectis plant sciences and Bayer CropScience extend their partnership to improve crops by gene editing

Read more
30
Jan 2014
21:30 E.S.T.

Precision BioSciences and Cellectis SA Announce Cross-License and Settlement Agreement for Gene Editing Technology

Read more
17
Jan 2014
21:30 E.S.T.

Axxam and Cellectis bioresearch announce their collaboration to offer a new generation of cell based assays

Read more
9
Jan 2014
21:30 E.S.T.

Cellectis plant sciences announce the finalization of the first glycosylation lines of their program

Read more
7
Jan 2014
21:30 E.S.T.

Cellectis reorganizes its Tools and Services business line, in partnership with Caisse des Dépôts, by contributing Ectycell’s shares to Cellectis bioresearch

Read more
5
Dec 2013
21:30 E.S.T.

Cellectis announces an acceleration of its strategic refocusing on therapeutics and agrobusiness

Read more
26
Sep 2013
20:30 E.S.T.

Cellectis announces first-half 2013 financial results

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US